Murine
|
SCN5A
+/−
mouse:
~50% reduction in INa, slowed conduction, conduction block, re-entrant arrhythmias and ventricular tachycardia [22].
Age and sex-related factors in disease progression [24,25,26,27,28].
Reduced Nav1.5 protein expression [33,34].
Fibrosis-related to decreased Nav1.5 expression [34].
Scn5a
1798insD mouse:
Bradycardia, QT prolongation and right ventricular conduction slowing [39].
Strain dependence of conduction defect caused by the Scn5a1798insD/+ [41].
|
Allows integral studies from the whole animal, organ, tissue, and single cells.
Ion channels can be knock out or modified.
|
|
Canine
|
Correlation between epicardial notch AP amplitude and J wave amplitude [43].
Transmural dispersion of repolarization leading to ST-segment elevation [16,43].
Repolarization abnormalities associated with ST-segment elevation are located in the right ventricular outflow tract [49].
Male/female differences in susceptibility to Brugada syndrome are related to gender differences in Ito [53].
Focused application of RFA to the epicardium might be more efficient in eradicating ventricular tachycardia in Brugada syndrome patients [56].
|
Allows investigation of cells in epicardium and endocardium preserving their structural organization in the heart.
Electrophysiological similarities with the human heart.
Profile of ion channel expression similar to the human heart.
|
|
Porcine
|
|
|
|
Heterologous expression
|
See Supplementary Table
|
|
Lack of many specific cardiac proteins.
Absence of patient-specific genetic background.
Results may vary according to the cell model (e.g.,: HEK cells vs. Xenopus oocytes).
|
iPS-CM
|
Reduced sodium current, increased triggered AP activity, and abnormal Ca2+ transients. Genome editing reversed the effects of the mutation, indicating causality [78].
Patients with no mutation identified do not present current abnormalities [79,80].
Decrease in current correlated with a reduction of the maximum upstroke velocity and AP amplitude [82].
Mutation-induced changes, other than current density may appear in patient-specific iPS-CM, but not in heterologous expression recordings [83].
No changes in sodium current were observed in iPS-CM from patients without SCN5A mutation [79].
|
Patient-specific iPS-CM carry the patient’s exact genetic background.
iPS-CM expression profile closely resembles that of cardiomyocytes.
iPS cells are suitable for genome editing.
|
Immature phenotype.
Depolarized membrane potential compared with adult cardiomyocytes.
Negligible levels of IK1.
Poor ultrastructural organization regarding sarcomere and t-tubule development.
|